Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Phospholipase D2 Antikörper:
anti-Rat (Rattus) Phospholipase D2 Antikörper:
anti-Mouse (Murine) Phospholipase D2 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal Phospholipase D2 Primary Antibody für ELISA, WB - ABIN393480
Oguin, Sharma, Stuart, Duan, Scott, Jones, Daniels, Lindsley, Thomas, Brown: Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition. in The Journal of biological chemistry 2014
Human Monoclonal Phospholipase D2 Primary Antibody für ELISA, WB - ABIN562269
Somers-Edgar, Taurin, Larsen, Chandramouli, Nelson, Rosengren: Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines. in Investigational new drugs 2011
PLD2 is involved into pathogenesis of a vast array of human diseases, and as such it can be targeted for therapy. (Review)
Slug is a positive regulator, and Snail (zeige SNAI1 Antikörper) a negative regulator, of PLD2 expression.
Data suggest that elevated membrane tension acts through phospholipase D2 (PLD2) and the mammalian target of rapamycin (zeige FRAP1 Antikörper) complex 2 (mTORC2 (zeige CRTC2 Antikörper)) to limit actin nucleation.
results suggest that the small GTPase (zeige RACGAP1 Antikörper) RalA (zeige rala Antikörper) plays an important role in promoting invagination and trafficking of caveolae, not by potentiating the association between Cav-1 (zeige CAV1 Antikörper) and FilA but by stimulating PLD2-mediated generation of phosphatidic acid.
Suggest PLD (zeige PLD Antikörper) expression in high grade serous ovarian carcinoma may have a role in mediating progression to effusions and chemoresistance.
PLD2 functions as a key mediator in the VEGF-mediated angiogenic functions of endothelial cells.
PLD2 protein itself interacts with HIF-1alpha (zeige HIF1A Antikörper), prolyl hydroxylase (PHD (zeige PDC Antikörper)) and VHL (zeige VHL Antikörper) to promote degradation of HIF-1alpha (zeige HIF1A Antikörper) via the proteasomal pathway independent of lipase (zeige LIPG Antikörper) activity.
PLD2-mediated production of phosphatidic acid contributed to the control of EGFR (zeige EGFR Antikörper) exposure to ligand through a multipronged transcriptional and posttranscriptional program during the out-of-control accumulation of EGFR (zeige EGFR Antikörper) signaling in cancer cells.
These results suggest that PLD2 expression in colon cancer cells is up-regulated via HIF1-alpha (zeige HIF1A Antikörper) in response to hypoxic stress and underscores the crucial role of HIF1-alpha (zeige HIF1A Antikörper)-induced PLD2 in tumor growth.
A 3D model of the PLD2 by combining homology and ab initio 3 dimensional structural modeling methods, and docking conformation, is reported.
Results suggest that PLD2 is the isoform that mediates aldosterone secretion and likely priming.
High PLD2 expression is associated with Lung Metastasis of Breast Cancer.
Pld1-/- and Pld2-/- mice present elevated free fatty acids (FFA) levels and are insulin (zeige INS Antikörper) as well as glucose intolerant. In conclusion, these data suggest that deficiency of PLD1 or PLD2 activity promotes development of overweight and diabetes.
PLD1/2 signaling pathways are involved in mitogenic signaling in astrocytes.
Data show that although phospholipase D PLD1 (zeige PLD Antikörper) deficiency impaired Fc epsilon receptor FcepsilonRI (zeige FCER1A Antikörper)-mediated signaling and mast cell function, phospholipase D (zeige PLD Antikörper) PLD2 deficiency actually enhanced these pathways.
PLD2 in neutrophils is essential for the pathogenesis of experimental sepsis
The impact of polyunsaturated fatty acid (PUFA) supplementation on phospholipase D (PLD (zeige PLD Antikörper)) trafficking and activity in mast cells was investigated.
AQP3 (zeige AQP3 Antikörper) has a pro-differentiative role in epidermal keratinocytes and PLD2 activity is necessary for this effect.
phosphatidic acid and phospholipase D1 and D2 have roles in leukocyte adhesion
PLD1 and PLD2 have roles in platelet alpha-granule secretion
The results indicate that PKC (zeige FYN Antikörper) could be the final target and an integrator molecule of different signaling pathways triggered by angiotensin II (Ang II), which could explain the sustained activation of Na(+)-ATPase (zeige DNAH8 Antikörper) by Ang II (zeige AGT Antikörper).
The protein encoded by this gene catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline. The activity of the encoded enzyme is enhanced by phosphatidylinositol 4,5-bisphosphate and ADP-ribosylation factor-1. This protein localizes to the peripheral membrane and may be involved in cytoskeletal organization, cell cycle control, transcriptional regulation, and/or regulated secretion. Two transcript variants encoding different isoforms have been found for this gene.
, phospholipase D2-like
, choline phosphatase 2
, phosphatidylcholine-hydrolyzing phospholipase D2
, PLD 2
, phospholipase D gene 2